Your browser doesn't support javascript.
loading
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
Lévy, Y; Lacabaratz, C; Lhomme, E; Wiedemann, A; Bauduin, C; Fenwick, C; Foucat, E; Surenaud, M; Guillaumat, L; Boilet, V; Rieux, V; Bouchaud, O; Girard, P-M; Molina, J-M; Morlat, P; Hocqueloux, L; Richert, L; Pantaleo, G; Lelièvre, J D; Thiébaut, R.
Affiliation
  • Lévy Y; Vaccine Research Institute-VRI, Hôpital Henri Mondor, Créteil, France yves.levy@aphp.fr.
  • Lacabaratz C; INSERM, Unité U955, Créteil, France.
  • Lhomme E; Université Paris-Est, Faculté de Médecine, UMR-S 955, Créteil, France.
  • Wiedemann A; Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Henri-Mondor Albert-Chenevier, Service d'Immunologie clinique, Créteil, France.
  • Bauduin C; Vaccine Research Institute-VRI, Hôpital Henri Mondor, Créteil, France.
  • Fenwick C; INSERM, Unité U955, Créteil, France.
  • Foucat E; Université Paris-Est, Faculté de Médecine, UMR-S 955, Créteil, France.
  • Surenaud M; Vaccine Research Institute-VRI, Hôpital Henri Mondor, Créteil, France.
  • Guillaumat L; University of Bordeaux, Department of Public Health, Inserm Bordeaux Population Health Research Centre, Inria SISTM, Bordeaux, France.
  • Boilet V; Pôle de Santé Publique, CHU de Bordeaux, Bordeaux, France.
  • Rieux V; Vaccine Research Institute-VRI, Hôpital Henri Mondor, Créteil, France.
  • Bouchaud O; INSERM, Unité U955, Créteil, France.
  • Girard PM; Université Paris-Est, Faculté de Médecine, UMR-S 955, Créteil, France.
  • Molina JM; University of Bordeaux, ISPED, Inserm, Population Health Research Center, Team MORPH3EUS, UMR 1219, CIC-EC 1401, Bordeaux, France.
  • Morlat P; Vaccine Research Institute-VRI, Hôpital Henri Mondor, Créteil, France.
  • Hocqueloux L; Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
  • Richert L; Vaccine Research Institute-VRI, Hôpital Henri Mondor, Créteil, France.
  • Pantaleo G; INSERM, Unité U955, Créteil, France.
  • Lelièvre JD; Université Paris-Est, Faculté de Médecine, UMR-S 955, Créteil, France.
  • Thiébaut R; Vaccine Research Institute-VRI, Hôpital Henri Mondor, Créteil, France.
J Virol ; 95(9)2021 04 12.
Article in En | MEDLINE | ID: mdl-33568510
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / AIDS Vaccines / Vaccines, DNA / Anti-Retroviral Agents Type of study: Clinical_trials / Qualitative_research Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Virol Year: 2021 Document type: Article Affiliation country: France Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / AIDS Vaccines / Vaccines, DNA / Anti-Retroviral Agents Type of study: Clinical_trials / Qualitative_research Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Virol Year: 2021 Document type: Article Affiliation country: France Country of publication: United States